any dispensing fee for the applicable drug. . 3. Maintenance of effort throughout the insulin supply chain (a) Elimination of PBM rebates Section 1128B(b)(3) of the Social Security Act (42 U.S.C. 1320a–7b(b)(3)) is amended— (1) in subparagraph (E), by inserting (except for a payment practice that permits rebates, discounts, or price concessions for insulin drugs (as defined in section 1150C(f)(3)) to be paid by a manufacturer to a PBM (as defined in section 1150A(a)) before the semicolon at the end